182 related articles for article (PubMed ID: 8943059)
1. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.
Ansieau S; Scheffrahn I; Mosialos G; Brand H; Duyster J; Kaye K; Harada J; Dougall B; Hübinger G; Kieff E; Herrmann F; Leutz A; Gruss HJ
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14053-8. PubMed ID: 8943059
[TBL] [Abstract][Full Text] [Related]
2. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.
Lee SY; Lee SY; Kandala G; Liou ML; Liou HC; Choi Y
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9699-703. PubMed ID: 8790394
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation.
Aizawa S; Nakano H; Ishida T; Horie R; Nagai M; Ito K; Yagita H; Okumura K; Inoue J; Watanabe T
J Biol Chem; 1997 Jan; 272(4):2042-5. PubMed ID: 8999898
[TBL] [Abstract][Full Text] [Related]
4. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.
Duckett CS; Gedrich RW; Gilfillan MC; Thompson CB
Mol Cell Biol; 1997 Mar; 17(3):1535-42. PubMed ID: 9032281
[TBL] [Abstract][Full Text] [Related]
5. A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation.
Horie R; Aizawa S; Nagai M; Ito K; Higashihara M; Ishida T; Inoue J; Watanabe T
Int Immunol; 1998 Feb; 10(2):203-10. PubMed ID: 9533448
[TBL] [Abstract][Full Text] [Related]
6. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
[TBL] [Abstract][Full Text] [Related]
7. Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression.
Miller WE; Cheshire JL; Raab-Traub N
Mol Cell Biol; 1998 May; 18(5):2835-44. PubMed ID: 9566902
[TBL] [Abstract][Full Text] [Related]
8. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.
Lee SY; Lee SY; Choi Y
J Exp Med; 1997 Apr; 185(7):1275-85. PubMed ID: 9104814
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
10. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins.
Gedrich RW; Gilfillan MC; Duckett CS; Van Dongen JL; Thompson CB
J Biol Chem; 1996 May; 271(22):12852-8. PubMed ID: 8662842
[TBL] [Abstract][Full Text] [Related]
11. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival.
Duckett CS; Thompson CB
Genes Dev; 1997 Nov; 11(21):2810-21. PubMed ID: 9353251
[TBL] [Abstract][Full Text] [Related]
12. CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2.
Tsitsikov EN; Wright DA; Geha RS
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1390-5. PubMed ID: 9037063
[TBL] [Abstract][Full Text] [Related]
13. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
14. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B.
Jang IK; Lee ZH; Kim YJ; Kim SH; Kwon BS
Biochem Biophys Res Commun; 1998 Jan; 242(3):613-20. PubMed ID: 9464265
[TBL] [Abstract][Full Text] [Related]
15. An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappaB activation but is dispensable for c-Jun N-terminal kinase signaling.
Dadgostar H; Cheng G
J Biol Chem; 1998 Sep; 273(38):24775-80. PubMed ID: 9733779
[TBL] [Abstract][Full Text] [Related]
16. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.
Galibert L; Tometsko ME; Anderson DM; Cosman D; Dougall WC
J Biol Chem; 1998 Dec; 273(51):34120-7. PubMed ID: 9852070
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors.
Lee SY; Park CG; Choi Y
J Exp Med; 1996 Feb; 183(2):669-74. PubMed ID: 8627180
[TBL] [Abstract][Full Text] [Related]
18. Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase.
Kim HH; Lee DE; Shin JN; Lee YS; Jeon YM; Chung CH; Ni J; Kwon BS; Lee ZH
FEBS Lett; 1999 Jan; 443(3):297-302. PubMed ID: 10025951
[TBL] [Abstract][Full Text] [Related]
19. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase.
Hatzoglou A; Roussel J; Bourgeade MF; Rogier E; Madry C; Inoue J; Devergne O; Tsapis A
J Immunol; 2000 Aug; 165(3):1322-30. PubMed ID: 10903733
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of a cDNA for rat CD30 homolog and chromosomal assignment of the genomic gene.
Aizawa S; Satoh H; Horie R; Ito K; Choi SH; Takeuchi H; Watanabe T
Gene; 1996 Dec; 182(1-2):155-62. PubMed ID: 8982082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
